CASI Pharmaceuticals Inc - Company Profile
Powered by
All the data and insights you need on CASI Pharmaceuticals Inc in one report.
- Save hours of research time and resources with
our up-to-date CASI Pharmaceuticals Inc Strategy Report
- Understand CASI Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
CASI Pharmaceuticals Inc (CASI) is a biopharmaceutical company, which focuses on the acquisition, development and commercialization of innovative therapies for the treatment of cancer. The company's focused research and development activities, patent portfolio and lead product ENMD-2076 helps it to maintain an edge in the industry. Growing incidence of cancer, regulatory approvals and business growth initiatives provide new growth avenues to the company. However, intense competition in the industry, dependence on third parties and government regulations could affect the company's growth prospects.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer